Edinburgh Research Explorer

Prof David Newby

BHF Duke of Edinburgh Chair of Cardiology

  1. 1999
  2. Placebo-controlled comparison of candoxatril, an orally active neutral endopeptidase inhibitor, and captopril in patients with chronic heart failure

    Northridge, D. B., Currie, P. F., Newby, D. E., McMurray, J. J., Ford, M., Boon, N. A. & Dargie, H. J., Mar 1999, In : European Journal of Heart Failure. 1, 1, p. 67-72 6 p.

    Research output: Contribution to journalArticle

  3. 1998
  4. Candoxatril improves exercise capacity in patients with chronic heart failure receiving angiotensin converting enzyme inhibition

    Newby, D. E., McDonagh, T., Currie, P. F., Northridge, D. B., Boon, N. A. & Dargie, H. J., Dec 1998, In : European Heart Journal. 19, 12, p. 1808-13 6 p.

    Research output: Contribution to journalArticle

  5. Reduced responsiveness to endothelin-1 in peripheral resistance vessels of patients with syndrome X

    Newby, D. E., Flint, L., Fox, K. A. A., Boon, N. A. & Webb, D. J., Jun 1998, In : Journal of the American College of Cardiology. 31, 7, p. 1585-90 6 p.

    Research output: Contribution to journalArticle

  6. A 'same day' direct-access chest pain clinic: improved management and reduced hospitalization

    Newby, D. E., Fox, K. A., Flint, L. L. & Boon, N. A., May 1998, In : QJM: An International Journal of Medicine. 91, 5, p. 333-7 5 p.

    Research output: Contribution to journalArticle

  7. The L-arginine/nitric oxide pathway contributes to the acute release of tissue plasminogen activator in vivo in man

    Newby, D. E., Wright, R. A., Dawson, P., Ludlam, C. A., Boon, N. A., Fox, K. A. & Webb, D. J., May 1998, In : Cardiovascular Research. 38, 2, p. 485-92 8 p.

    Research output: Contribution to journalArticle

  8. Peripheral vascular tone in patients with cirrhosis: role of the renin-angiotensin and sympathetic nervous systems

    Newby, D. E., Jalan, R., Masumori, S., Hayes, P. C., Boon, N. A. & Webb, D. J., Apr 1998, In : Cardiovascular Research. 38, 1, p. 221-8 8 p.

    Research output: Contribution to journalArticle

  9. Endothelin-A receptor antagonist-mediated vasodilatation is attenuated by inhibition of nitric oxide synthesis and by endothelin-B receptor blockade

    Verhaar, M. C., Strachan, F. E., Newby, D. E., Cruden, N. L., Koomans, H. A., Rabelink, T. J. & Webb, D. J., 3 Mar 1998, In : Circulation. 97, 8, p. 752-6 5 p.

    Research output: Contribution to journalArticle

  10. Regulation of peripheral vascular tone in patients with heart failure: Contribution of angiotensin II

    Newby, D. E., Webb, D. J., Flapan, A. D., Boon, N. A., Fox, K. A. A. & Goodfield, N. E. R., 1 Jan 1998, In : Heart. 80, 2, p. 134-141 8 p.

    Research output: Contribution to journalArticle

  11. 1997
  12. Endogenous angiotensin II contributes to basal peripheral vascular tone in sodium deplete but not sodium replete man

    Newby, D. E., Masumori, S., Johnston, N. R., Boon, N. A. & Webb, D. J., Nov 1997, In : Cardiovascular Research. 36, 2, p. 268-75 8 p.

    Research output: Contribution to journalArticle

  13. The peptide endothelin receptor antagonist, TAK-044, produces sustained inhibition of endothelin-1 mediated arteriolar vasoconstriction

    Ferro, C. J., Haynes, W. G., Johnston, N. R., Lomax, C. C., Newby, D. E. & Webb, D. J., Oct 1997, In : British Journal of Clinical Pharmacology. 44, 4, p. 377-83 7 p.

    Research output: Contribution to journalArticle